C4 Therapeutics, Inc.

NASDAQ:CCCC

2.02 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 55.49959.64973.11489.659126.5960.97144.88149.47629.75449.55157.29646.00476.124162.745281.14694.912181.72763.434112.152-90.54990.549-36.311
Short Term Investments 189.405195.992190.984168.533127.091155.598222.404220.849246.399264.102250.484245.17233.155239.326184.765218.567189.962135.979103.942181.098072.622
Cash and Short Term Investments 244.904255.641264.098258.192253.681216.569286.7305.031276.153313.653307.78291.174309.279402.071465.911313.479371.689199.413216.09490.54990.54936.311
Net Receivables 3.10210.3411.16713.59911.7990.51.0280.5281.4731.4881.7091.7735.7164.8456.2133.6564.4844.1418.54604.6230
Inventory 000000-19.415-34.70600000000000000
Other Current Assets 9.7617.24610.7797.8015.7096.6176.0747.5999.93120.6317.75219.99821.38810.75610.8749.7529.67210.743.27801.5950
Total Current Assets 257.767273.228276.044279.592271.189223.686274.387278.452287.557325.456318.365302.946325.689412.294477.561322.011381.009208.924227.91890.54996.76736.311
Non-Current Assets:
Property, Plant & Equipment, Net 63.37865.37367.35269.13371.08872.8174.63976.23977.51679.03379.45977.85435.05315.57216.23516.92416.55217.12317.572018.9160
Goodwill 0000000000000000000000
Intangible Assets 0000000000000000000000
Goodwill and Intangible Assets 0000000000000000000000
Long Term Investments 22.359035.0844.41831.45129.85719.41534.70660.96252.35890.057130.478142.278.19132.7732.495189.96200000
Tax Assets 0000000000000000000000
Other Non-Current Assets 6.09837.4592.6175.2282.7236.666.5676.6394.8054.5924.5944.2073.8231.8541.8552.577-187.3853.0792.577-90.5492.577-36.311
Total Non-Current Assets 91.835102.832105.049118.779105.262109.327100.621117.584143.283135.983174.11212.539181.07695.61750.8651.99619.12920.20220.149-90.54921.493-36.311
Total Assets 349.602376.06381.093398.371376.451333.013375.008396.036430.84461.439492.475515.485506.765507.911528.421374.007400.138229.127248.0670118.260
Liabilities & Equity:
Current Liabilities:
Account Payables 1.3281.5040.9131.631.4461.2762.2471.0341.1722.374.4463.4054.5063.7454.4693.7425.6835.2645.86105.3850
Short Term Debt 5.77411.26410.9865.35510.43810.17420.2477.11411.68711.4044.3984.2041.3342.3542.2622.1721.04220.95900.880
Tax Payables 0000000000000000000000
Deferred Revenue 18.71220.76936.59235.14215.4718.42438.61830.78216.61818.12922.1731.26631.832.29428.69526.56527.60323.91522.165020.7050
Other Current Liabilities 19.3639.7565.7112.89115.41110.39711.77316.29515.06913.36415.1348.11313.60610.2948.745.1749.5248.836.12906.6710
Total Current Liabilities 45.17743.29354.20155.01842.76630.27148.23839.3844.54645.26746.14846.98851.24648.68744.16637.65343.85240.00935.114033.6410
Non-Current Liabilities:
Long Term Debt 59.98261.463125.84864.365131.514134.19136.83278.34180.165153.404157.114159.70241.54532.42832.86921.76321.87834.07122.035012.8690
Deferred Revenue Non-Current 28.45728.64816.9120.70621.81419.62324.64715.84516.89516.76517.99119.0224.36838.93646.18950.88653.61761.08367.137072.7180
Deferred Tax Liabilities Non-Current 00-16.91-20.706-21.814-19.623-24.6478.6219.1959.05210.372-19.02-24.368-38.936-46.189-50.886-11.826-12.097-12.3610-12.8690
Other Non-Current Liabilities 00-62.9240-65.757-67.095-68.41600-72.176-73.371-74.7540-10.92-11.2300-6.63200110.9950
Total Non-Current Liabilities 88.43990.11179.83485.07187.57186.71893.06394.18697.0697.993101.734103.96865.91360.44467.82872.64975.495345.04289.1720196.5820
Total Liabilities 133.616133.404134.035140.089130.337116.989141.301133.566141.606143.26147.882150.956117.159109.131111.994110.302119.347385.051124.2860230.2230
Equity:
Preferred Stock 000000000000000001252.021110.995110.995110.995
Common Stock 0.0070.0070.0070.0070.0060.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0040.0040.0010.004000
Retained Earnings -633.699-599.126-574.46-556.744-528.383-493.629-466.592-430.67-395.89-358.705-326.747-299.335-267.715-252.057-227.374-204.794-183.823-162.028-140.1930-117.4880
Accumulated Other Comprehensive Income/Loss 0.0530.455-0.44-0.38-0.127-0.904-1.774-2.47-4.137-5.409-4.581-3.65-0.775-0.155-0.069-0.0940.0130.008-0.002-111.963-3.954-79.75
Other Total Stockholders Equity 849.625841.32821.951815.399774.618710.552702.068695.605689.256682.288675.916667.509658.091650.987643.865468.589464.5971263.9720-105.470
Total Shareholders Equity 215.986242.656247.058258.282246.114216.024233.707262.47289.234318.179344.593364.529389.606398.78416.427263.705280.791-155.924123.781-0.968-111.96331.245
Total Equity 215.986242.656247.058258.282246.114216.024233.707262.47289.234318.179344.593364.529389.606398.78416.427263.705280.791-155.924123.781-0.968-111.96331.245
Total Liabilities & Shareholders Equity 349.602376.06381.093398.371376.451333.013375.008396.036430.84461.439492.475515.485506.765507.911528.421374.007400.138229.127248.067-0.968118.2631.245